Id |
Subject |
Object |
Predicate |
Lexical cue |
T644 |
0-9 |
Sentence |
denotes |
Table 12. |
T645 |
11-100 |
Sentence |
denotes |
Best docking poses of human and viral target proteins with selected WS phytoconstituents. |
T646 |
101-155 |
Sentence |
denotes |
Ligands AutoDock v4.2.6 AutoDock vina iGEMDOCK v2.1 |
T647 |
156-161 |
Sentence |
denotes |
12.1. |
T648 |
162-238 |
Sentence |
denotes |
Best docking poses of WS phytoconstituents with human ACE2 receptor (PDB ID: |
T649 |
239-326 |
Sentence |
denotes |
1O8A) in comparison to the FDA approved standard reference drugs (Arbidol and Losartan) |
T650 |
327-339 |
Sentence |
denotes |
Withaferin A |
T651 |
340-353 |
Sentence |
denotes |
Withanolide A |
T652 |
354-367 |
Sentence |
denotes |
Withanolide B |
T653 |
368-381 |
Sentence |
denotes |
Withanolide D |
T654 |
382-395 |
Sentence |
denotes |
Withanolide E |
T655 |
396-405 |
Sentence |
denotes |
Withanone |
T656 |
406-422 |
Sentence |
denotes |
Viscosalactone B |
T657 |
423-432 |
Sentence |
denotes |
Anaferine |
T658 |
433-445 |
Sentence |
denotes |
Withasomnine |
T659 |
446-453 |
Sentence |
denotes |
Arbidol |
T660 |
454-462 |
Sentence |
denotes |
Losartan |
T661 |
463-468 |
Sentence |
denotes |
12.2. |
T662 |
469-553 |
Sentence |
denotes |
Best docking poses of WS phytoconstituents with SARS-CoV spike glycoprotein (PDB ID: |
T663 |
554-651 |
Sentence |
denotes |
5WRG) in comparison to the FDA approved standard reference drugs (Arbidol and Hydroxychloroquine) |
T664 |
652-664 |
Sentence |
denotes |
Withaferin A |
T665 |
665-678 |
Sentence |
denotes |
Withanolide A |
T666 |
679-692 |
Sentence |
denotes |
Withanolide B |
T667 |
693-706 |
Sentence |
denotes |
Withanolide D |
T668 |
707-720 |
Sentence |
denotes |
Withanolide E |
T669 |
721-730 |
Sentence |
denotes |
Withanone |
T670 |
731-747 |
Sentence |
denotes |
Viscosalactone B |
T671 |
748-757 |
Sentence |
denotes |
Anaferine |
T672 |
758-770 |
Sentence |
denotes |
Withasomnine |
T673 |
771-778 |
Sentence |
denotes |
Arbidol |
T674 |
779-797 |
Sentence |
denotes |
Hydroxychloroquine |
T675 |
798-803 |
Sentence |
denotes |
12.3. |
T676 |
804-890 |
Sentence |
denotes |
Best docking poses of WS phytoconstituents with SARS-CoV-2 spike glycoprotein (PDB ID: |
T677 |
891-984 |
Sentence |
denotes |
6VXX) in comparison to FDA approved standard reference drugs (Arbidol and Hydroxychloroquine) |
T678 |
985-997 |
Sentence |
denotes |
Withaferin A |
T679 |
998-1011 |
Sentence |
denotes |
Withanolide A |
T680 |
1012-1025 |
Sentence |
denotes |
Withanolide B |
T681 |
1026-1039 |
Sentence |
denotes |
Withanolide D |
T682 |
1040-1053 |
Sentence |
denotes |
Withanolide E |
T683 |
1054-1063 |
Sentence |
denotes |
Withanone |
T684 |
1064-1080 |
Sentence |
denotes |
Viscosalactone B |
T685 |
1081-1090 |
Sentence |
denotes |
Anaferine |
T686 |
1091-1103 |
Sentence |
denotes |
Withasomnine |
T687 |
1104-1111 |
Sentence |
denotes |
Arbidol |
T688 |
1112-1130 |
Sentence |
denotes |
Hydroxychloroquine |
T689 |
1131-1136 |
Sentence |
denotes |
12.4. |
T690 |
1137-1228 |
Sentence |
denotes |
Best docking poses of WS phytoconstituents with papain like protease of SARS-CoV-2 (PDB ID: |
T691 |
1229-1323 |
Sentence |
denotes |
6W9C) in comparison to the FDA approved standard reference drugs (Procainamide and Cinacalcet) |
T692 |
1324-1336 |
Sentence |
denotes |
Withaferin A |
T693 |
1337-1350 |
Sentence |
denotes |
Withanolide A |
T694 |
1351-1364 |
Sentence |
denotes |
Withanolide B |
T695 |
1365-1378 |
Sentence |
denotes |
Withanolide D |
T696 |
1379-1392 |
Sentence |
denotes |
Withanolide E |
T697 |
1393-1402 |
Sentence |
denotes |
Withanone |
T698 |
1403-1419 |
Sentence |
denotes |
Viscosalactone B |
T699 |
1420-1429 |
Sentence |
denotes |
Anaferine |
T700 |
1430-1442 |
Sentence |
denotes |
Withasomnine |
T701 |
1443-1455 |
Sentence |
denotes |
Procainamide |
T702 |
1456-1466 |
Sentence |
denotes |
Cinacalcet |
T703 |
1467-1472 |
Sentence |
denotes |
12.5. |
T704 |
1473-1560 |
Sentence |
denotes |
Best docking poses of WS phytoconstituents with SARS-CoV main protease/3CL-pro (PBB ID: |
T705 |
1561-1653 |
Sentence |
denotes |
1P9U) in comparison to the FDA approved standard reference drugs (Oberadilol and Poziotinib) |
T706 |
1654-1666 |
Sentence |
denotes |
Withaferin A |
T707 |
1667-1680 |
Sentence |
denotes |
Withanolide A |
T708 |
1681-1694 |
Sentence |
denotes |
Withanolide B |
T709 |
1695-1708 |
Sentence |
denotes |
Withanolide D |
T710 |
1709-1722 |
Sentence |
denotes |
Withanolide E |
T711 |
1723-1732 |
Sentence |
denotes |
Withanone |
T712 |
1733-1749 |
Sentence |
denotes |
Viscosalactone B |
T713 |
1750-1759 |
Sentence |
denotes |
Anaferine |
T714 |
1760-1772 |
Sentence |
denotes |
Withasomnine |
T715 |
1773-1783 |
Sentence |
denotes |
Oberadilol |
T716 |
1784-1794 |
Sentence |
denotes |
Poziotinib |
T717 |
1795-1800 |
Sentence |
denotes |
12.6. |
T718 |
1801-1890 |
Sentence |
denotes |
Best docking poses of WS phytoconstituents with SARS-CoV-2 main protease/3CL-pro (PDB ID: |
T719 |
1891-1983 |
Sentence |
denotes |
6LU7) in comparison to the FDA approved standard reference drugs (Oberadilol and Poziotinib) |
T720 |
1984-1996 |
Sentence |
denotes |
Withaferin A |
T721 |
1997-2010 |
Sentence |
denotes |
Withanolide A |
T722 |
2011-2024 |
Sentence |
denotes |
Withanolide B |
T723 |
2025-2038 |
Sentence |
denotes |
Withanolide D |
T724 |
2039-2052 |
Sentence |
denotes |
Withanolide E |
T725 |
2053-2062 |
Sentence |
denotes |
Withanone |
T726 |
2063-2079 |
Sentence |
denotes |
Viscosalactone B |
T727 |
2080-2089 |
Sentence |
denotes |
Anaferine |
T728 |
2090-2102 |
Sentence |
denotes |
Withasomnine |
T729 |
2103-2113 |
Sentence |
denotes |
Oberadilol |
T730 |
2114-2124 |
Sentence |
denotes |
Poziotinib |
T731 |
2125-2130 |
Sentence |
denotes |
12.7. |
T732 |
2131-2225 |
Sentence |
denotes |
Best docking poses of WS phytoconstituents with Nsp-10/Nsp-16 complex from SARS-CoV-2 (PDB ID: |
T733 |
2226-2324 |
Sentence |
denotes |
6W75) in comparison to the FDA approved standard reference drugs (Losartan and Hydroxychloroquine) |
T734 |
2325-2337 |
Sentence |
denotes |
Withaferin A |
T735 |
2338-2351 |
Sentence |
denotes |
Withanolide A |
T736 |
2352-2365 |
Sentence |
denotes |
Withanolide B |
T737 |
2366-2379 |
Sentence |
denotes |
Withanolide D |
T738 |
2380-2393 |
Sentence |
denotes |
Withanolide E |
T739 |
2394-2403 |
Sentence |
denotes |
Withanone |
T740 |
2404-2420 |
Sentence |
denotes |
Viscosalactone B |
T741 |
2421-2430 |
Sentence |
denotes |
Anaferine |
T742 |
2431-2443 |
Sentence |
denotes |
Withasomnine |
T743 |
2444-2452 |
Sentence |
denotes |
Losartan |
T744 |
2453-2471 |
Sentence |
denotes |
Hydroxychloroquine |